Big Health acquires Limbix, maker of mental health app for depression in adolescents

Big Health, one of the leading companies producing apps to help treat mental health conditions, on Thursday announced it acquired Limbix, developer of a prescription app for adolescent depression.

The terms of the deal were not disclosed, but the acquisition comes at a time when many digital health companies are running into trouble raising money. Developers of prescription digital therapeutics, in particular, have been reeling. Limbix last raised $15 million in late 2021, at the peak of the digital health fundraising boom.

Big Health CEO Arun Gupta said that his company has repeatedly heard from employer and health plan customers that they need a solution for adolescent mental health, an area where there’s growing need and care is hard to find. Limbix recently completed a pivotal clinical trial of its depression treatment, SparkRx, and also has an early-stage product in development to treat adolescent anxiety.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In